Regent’s Park Healthcare shortlisted for two categories at HSJ Partnership Awards 2026

WILTSHIRE, United Kingdom, 5 February 2026: Regent’s Park Healthcare (RPH) has been shortlisted as a finalist across two categories at the HSJ Partnership Awards 2026:

• Most Effective Contribution to Clinical Redesign

  Entry: “Twenty years of Clinical Pathway Transformation across Cardiology Services.”

  
  

• Best Contribution to Improving the Efficiency of NHS Services

  Entry: “20 years of Delivering World-class Cardiology Services in Partnership with the NHS.”

RPH in partnership with University Hospital Plymouth NHS Trust (UHP) operate Peninsula Heart Clinic (PHC) - a focused elective cardiac diagnostic and treatment centre, opened in 2019, that links referral triage, digital pre-assessment & e-consent, standardised cath-lab bundles, 4.5-minute turnarounds and e-discharge within 24 hours, all under joint MAC governance and interoperable IT. The single pathway spans diagnostics, PCI, complex electrophysiology and pacing.

Peninsula Heart Clinic Impact highlights:

• 20,000+ cardiac procedures delivered

• Elective waits reduced from >12 months to <6 weeks within six months of launch

• Average same-day LOS ~4.25 hours; DNAs down 6.7%

• BCIS Top-7 in the UK for NSTEMI PCI <72h (~81% vs 75% target)

• Strong public feedback (c. 1200+ Doctify reviews) alongside 100% FFT

• £7.5m+ efficiency savings to date (below-tariff pricing model), retained by UHP
  

Dr Anil Ohri, Chief Executive Officer, Regent’s Park Healthcare, said: “Being shortlisted in both Clinical Redesign and Efficiency is a tribute to the quiet excellence of our teams and our enduring partnership with UHP. Most importantly, it recognises a pathway that shortens waits, reassures patients and delivers real value to the NHS. After more than two decades working alongside the wider NHS system, and around 270,000 procedures delivered, this recognition means a great deal.” He added: PHC is also now one of only ten pilot centres across the UK to pilot the latest Pulse Field Ablation (VARIPULSE) Electrophysiology technology from J&J, which is set to improve efficiency further: reduced length of procedure, less anaesthesia time, accelerated discharge, and crucially improved patient outcomes.

The final award ceremony takes place in London on 19 March 2026.